Do we need high-resolution MS in forensic and clinical toxicology?

Bioanalysis

Volumn 5, Issue 10, 2013, Pages 1161-1163

  Meyer, Markus R ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

clinical toxicology; forensic toxicology; HRMS; quantification; research; screening

Indexed keywords

CLINICAL TOXICOLOGY; FORENSIC TOXICOLOGY; HUMAN; IMMUNOASSAY; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; MOLECULAR MODEL; NOTE; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; TOXICOLOGY;

CLINICAL LABORATORY TECHNIQUES; DRUG MONITORING; FORENSIC TOXICOLOGY; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MASS SPECTROMETRY; PROTEOMICS; STREET DRUGS; SUBSTANCE ABUSE DETECTION; TOXICITY TESTS;

EID: 84878502151     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.13.70     Document Type: Note

References (14)

1. Meyer MR, Maurer HH. Current applications of high-resolution mass spectrometry in drug metabolism studies. Anal. Bioanal. Chem. 403(5), 1221-1231 (2012).
2. Liu Z-Y. An introduction to hybrid ion trap/time-of-fight mass spectrometry coupled with liquid chromatography applied to drug metabolism studies. J. Mass Spectrom. 47(12), 1627-1642 (2012).
3. Bateman K P, Kellmann M, Muenster H, Papp R, Taylor L. Quantitative-qualitative data acquisition using a benchtop Orbitrap mass spectrometer. J. Am. Soc. Mass Spectrom. 20 (8), 1441-1450 (2009).
4. Wagner DS, Pirhalla JL, Bowers GD. Metabolite structure analysis by high-resolution MS: supporting drug-development studies. Bioanalysis 5(4), 463-479 (2013).
5. Du F, Ruan Q, Zhu M, Xing J. Detection and characterization of ticlopidine conjugates in rat bile using high-resolution mass spectrometry: applications of various data acquisition and processing tools. J. Mass Spectrom. 48(3), 413-422 (2013).
6. Ojanperä I, Kolmonen M, Pelander A. Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control. Anal. Bioanal. Chem. 403(5), 1203-1220 (2012).
7. Thevis M, Thomas A, Schänzer W. Current role of LC-MS(/MS) in doping control. Anal. Bioanal. Chem. 401(2), 405-420 (2011).
8. Crews BO, Pesce AJ, West R, Nguyen H, Fitzgerald RL. Evaluation of high-resolution mass spectrometry for urine toxicology screening in a pain management setting. J. Anal. Toxicol. 36(9), 601-607 (2012).
9. Broecker S, Herre S, Pragst F. General unknown screening in hair by liquid chromatography-hybrid quadrupole time-of-fight mass spectrometry (LC-QTOF-MS). Forensic Sci Int. 218(1-3), 68-81 (2012).
10. Bruce SJ, Rochat B, Béguin A, et al. Analysis and quantifcation of vitamin D metabolites in serum by ultra-performance liquid chromatography coupled to tandem mass spectrometry and high-resolution mass spectrometry-a method comparison and validation. Rapid Commun. Mass Spectrom. 27(1), 200-206 (2013).
11. Wode F, Reilich C, van Baar P, Dünnbier U, Jekel M, Reemtsma T. Multiresidue analytical method for the simultaneous determination of 72 micropollutants in aqueous samples with ultra high performance liquid chromatography-high resolution mass spectrometry. J. Chromatogr. A 1270, 118-126 (2012).
12. Wu AH, Gerona R, Armenian P, French D, Petrie M, Lynch KL. Role of liquid chromatography-high-resolution mass spectrometry (LC-HRMS) in clinical toxicolog y. Clin. Toxicol. (Phila.) 50(8), 733-742 (2012).
13. Pelander A, Tyrkkö E, Ojanperä I. In silico methods for predicting metabolism and mass fragmentation applied to quetiapine in liquid chromatography-time-of-fight mass spectrometry urine drug screening. Rapid Commun. Mass Spectrom. 23(4), 506-514 (2009).
14. Peters F T. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology. Clin. Biochem. 44(1), 54-65 (2011).